Integrin-linked kinase - Essential roles in physiology and cancer biology

Journal of Cell Science

Volumn 121, Issue 19, 2008, Pages 3121-3132

  McDonald, Paul C ^a   Fielding, Andrew B ^a   Dedhar, Shoukat ^a,b  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cancer; Development; Extracellular matrix; Integrin linked kinase; Protein protein interaction; Signal transduction

Indexed keywords

CETUXIMAB; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; GEFITINIB; GEMCITABINE; INTEGRIN LINKED KINASE; INTEGRIN LINKED KINASE INHIBITOR; KP 15792; KP 392; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE INHIBITOR; QLT 0254; QLT 0267; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AGYRIA; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLISTER; CANCER RESEARCH; CANCER RESISTANCE; CARTILAGE CELL; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COMBINATION CHEMOTHERAPY; CONGESTIVE CARDIOMYOPATHY; DRUG POTENCY; DRUG TARGETING; DWARFISM; ENZYME INHIBITION; GENE OVEREXPRESSION; HEPATITIS; HUMAN; KIDNEY FIBROSIS; LIVER CELL CARCINOMA; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MITOSIS; MOLECULAR MECHANICS; MONOTHERAPY; MUSCULAR DYSTROPHY; NONHUMAN; ORGANOGENESIS; PANCREAS CANCER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEINURIA; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; STRUCTURE ACTIVITY RELATION; TUMOR XENOGRAFT; VASCULARIZATION;

ANIMALS; EMBRYONIC DEVELOPMENT; HUMANS; MITOSIS; NEOPLASMS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 47749087950     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.017996     Document Type: Article

References (109)

1. Abboud, E. R., Coffelt, S. B., Figueroa, Y. G., Zwezdaryk K. J., Nelson, A. B., Sullivan, D. E., Morris, C. B., Tang, Y., Beckman, B. S. and Scandurro, A. B. (2007). Integrin-linked kinase: a hypoxia-induced anti-apoptotic factor exploited by cancer cells. Int. J. Oncol. 30, 113-122.
2. Assi, K., Mills, J., Owen, D., Ong, C., St Arnaud, R., Dedhar, S. and Salh, B. (2008). Integrin-linked kinase regulates cell proliferation and tumor growth in murine colitis-associated carcinogenesis. Gut 57, 931-940.
3. Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C. et al. (2007). Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat. Biotechnol. 25, 1035-1044.
4. Barbera, M. J., Puig, I., Dominguez, D., Julien-Grille, S., Guaita-Esteruelas, S., Peiro, S., Baulida, J., Franci, C., Dedhar, S., Larue, L. et al. (2004). Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 23, 7345-7354.
5. Basaki, Y., Hosoi, F., Oda, Y., Fotovati, A., Maruyama, Y., Oie, S., Ono, M., Izumi, H., Kohno, K., Sakai, K. et al. (2007). Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene 26, 2736-2746.
6. Belvindrah, R., Nalbant, P., Ding, S., Wu, C., Bokoch, G. M. and Muller, U. (2006). Integrin-linked kinase regulates Bergmann glial differentiation during cerebellar development. Mol. Cell. Neurosci. 33, 109-125.
7. Bendig, G., Grimmler, M., Huttner, I. G., Wessels, G., Dahme, T., Just, S., Trano, N., Katus, H. A., Fishman, M. C. and Rottbauer, W. (2006). Integrin-linked kinase, a novel component of the cardiac mechanical stretch sensor, controls contractility in the zebrafish heart. Genes Dev. 20, 2361-2372.
8. Bettencourt-Dias, M., Giet, R., Sinka, R., Mazumdar, A., Lock, W. G., Balloux, F., Zafiropoulos, P. J., Yamaguchi, S., Winter, S., Carthew, R. W. et al. (2004). Genome-wide survey of protein kinases required for cell cycle progression. Nature 432, 980-987.
9. Blaess, S., Graus-Porta, D., Belvindrah, R., Radakovits, R., Pons, S., Littlewood-Evans, A., Senften, M., Guo, H., Li, Y., Miner, J. H. et al. (2004). Beta1-integrins are critical for cerebellar granule cell precursor proliferation. J. Neurosci. 24, 3402-3412.
10. Blattner, S. M. and Kretzler, M. (2005). Integrin-linked kinase in renal disease: connecting cell-matrix interaction to the cytoskeleton. Curr. Opin. Nephrol. Hypertens. 14, 404-410.
11. Brancaccio, M., Fratta, L., Notte, A., Hirsch, E., Poulet, R., Guazzone, S., De Acetis, M., Vecchione, C., Marino, G., Altruda, F. et al. (2003). Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nat. Med. 9, 68-75.
12. Chu, H., Thievessen, I., Sixt, M., Lammermann, T., Waisman, A., Braun, A., Noegel, A. A. and Fassler, R. (2006). gamma-Parvin is dispensable for hematopoiesis, leukocyte trafficking, and T-cell-dependent antibody response. Mol. Cell. Biol. 26, 1817-1825.
13. Cruet-Hennequart, S., Maubant, S., Luis, J., Gauduchon, P., Staedel, C. and Dedhar, S. (2003). alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Oncogene 22, 1688-1702.
14. Dai, C., Stolz, D. B., Bastacky, S. L, St-Arnaud, R., Wu, C., Dedhar, S. and Liu, Y. (2006). Essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling. J. Am. Soc. Nephrol. 17, 2164-2175.
15. Dai, D. L., Makretsov, N., Campos, E. L, Huang, C., Zhou, Y., Huntsman, D., Martinka, M. and Li, G. (2003). Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival. Clin. Cancer Res. 9, 4409-4414.
16. Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J. and Dedhar, S. (1998). Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc. Natl. Acad. Sci. USA 95, 11211-11216.
17. 2+-independent smooth muscle contraction. a novel function for integrin-linked kinase. J. Biol. Chem. 276, 16365-16373.
18. Deng, J. T., Sutherland, C., Brautigan, D. L., Eto, M. and Walsh, M. P. (2002). Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase. Biochem. J. 367, 517-524.
19. Dillon, R. L., White, D. E. and Muller, W. J. (2007). The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer. Oncogene 26, 1338-1345.
20. Dobreva, L, Fielding, A., Foster, L. J. and Dedhar, S. (2008). Mapping the Integrin-Linked Kinase Interactome Using SILAC. J. Proteome Res, 7, 1740-1749.
21. Duxbury, M. S., Ito, H., Benoit, E., Waseem, T., Ashley, S. W. and Whang, E. E. (2005). RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance. Clin. Cancer Res. 11, 3433-3438.
22. Edwards, L. A., Thiessen, B., Dragowska, W. H., Daynard, T., Bally, M. B. and Dedhar, S. (2005). Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth. Oncogene 24, 3596-3605.
23. Edwards, L. A., Verreault, M., Thiessen, B., Dragowska, W. H., Hu, Y., Yeung, J. H., Dedhar, S. and Bally, M. B. (2006). Combined inhibition of the phosphatidylinositol 3-kinase/Akt and Ras/ mitogen-activated protein kinase pathways results in synergistic effects in glioblastoma cells. Mol. Cancer Ther. 5, 645-654.
24. Edwards, L. A., Woo, J., Huxham, L. A., Verreault, M., Dragowska, W. H., Chiu, G., Rajput, A., Kyle, A. H., Kalra, J., Yapp, D. et al. (2008). Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of Integrin-linked kinase (ILK). Mol. Cancer Ther. 7, 59-70.
25. El-Aouni, C., Herbach, N., Blattner, S. M., Henger, A., Rastaldi, M. P., Jarad, G., Miner, J. H., Moeller, M. J., St-Arnaud, R., Dedhar, S. et al. (2006). Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis. J. Am. Soc. Nephrol. 17, 1334-1344.
26. Erdodi, F., Kiss, E., Walsh, M. P., Stefansson, B., Deng, J. T., Eto, M., Brautigan, D. L. and Hartshorne, D. J. (2003). Phosphorylation of protein phosphatase type-1 inhibitory proteins by integrin-linked kinase and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 306, 382-387.
27. Fielding, A. B., Dobreva, I., McDonald, P. C., Foster, L. J. and Dedhar, S. (2008). Integrin-linked kinase localizes to the centrosome and regulates mitotic spindle organization. J. Cell Biol. 180, 681-689.
28. Filipenko, N. R., Attwell, S., Roskelley, C. and Dedhar, S. (2005). Integrin-linked kinase activity regulates Rac- and Cdc42-mediated actin cytoskeleton reorganization via alpha-PIX. Oncogene 38, 5837-5849.
29. Friedrich, E. B., Liu, E., Sinha, S., Cook, S., Milstone, D. S., MacRae, C. A., Mariotti, M., Kuhlencordt, P. J., Force, T., Rosenzweig, A. et al. (2004). Integrin-Linked Kinase regulates endothelial cell survival and vascular develpment. Mol. Cell. Biol. 24, 8134-8144.
30. Fuchs, B. C., Fujii, T., Dorfman, J. D., Goodwin, J. M., Zhu, A. X., Lanuti, M. and Tanabe, K. K. (2008). Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res. 68, 2391-2399.
31. Gary, D. S., Milhavet, O., Camandola, S. and Mattson, M. P. (2003). Essential role for integrin linked kinase in Akt-mediated integrin survival signaling in hippocampal neurons. J. Neurochem. 84, 878-890.
32. Gheyara, A. L., Vallejo-Illarramendi, A., Zang, K., Mei, L., St-Arnaud, R., Dedhar, S. and Reichardt, L. F. (2007). Deletion of integrin-linked kinase from skeletal muscles of mice resembles muscular dystrophy due to alpha 7 beta 1-integrin deficiency. Am. J. Pathol. 171, 1966-1977.
33. Gkretsi, V., Bowen, W. C., Yang, Y., Wu, C. and Michalopoulos, G. K. (2007a). Integrin-linked kinase is involved in matrix-induced hepatocyte differentiation. Biochem. Biophys. Res. Commun. 353, 638-643.
34. Gkretsi, V., Mars, W. M., Bowen, W. C., Barua, L., Yang, Y., Goo, L., St-Arnaud, R., Dedhar, S., Wu, C. and Michalopoulos, G. K. (2007b). Loss of integrin linked kinase from mouse hepatocytes in vitro and in vivo results in apoptosis and hepatitis. Hepatology 45, 1025-1034.
35. Graff, J. R., Deddens, J. A., Konicek, B. W., Colligan, B. M., Hurst, B. M., Carter, H. W. and Carter, J. H. (2001). Integrin-linked kinase expression increases with prostate tumor grade. Clin. Cancer Res. 7, 1987-1991.
36. Grashoff, C., Aszodi, A., Sakai, T., Hunziker, E. B. and Fassler, R. (2003). Integrin-linked kinase regulates chondrocyte shape and proliferation. EMBO Rep. 4, 432-438.
37. Graus-Porta, D., Blaess, S., Senften, M., Littlewood-Evans, A., Damsky, C., Huang, Z., Orban, P., Klein, R., Schittny, J. C. and Muller, U. (2001). Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron 31, 367-379.
38. Guo, W., Jiang, H., Gray, V., Dedhar, S. and Rao, Y. (2007). Role of the integrin-linked kinase (ILK) in determining neuronal polarity. Dev. Biol. 306, 457-468.
39. Hannigan, G. E., Leung-Hagesteijn, C., Fitz-Gibbon, L., Coppolino, M. G., Radeva, G., Filmus, J., Bell, J. C. and Dedhar, S. (1996). Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 379, 91-96.
40. Hannigan, G., Troussard, A. A. and Dedhar, S. (2005). Integrin-finked kinase: a cancer therapeutic target unique among its ILK. Nat. Rev. Cancer 5, 51-63.
41. Hannigan, G. E., Coles, J. G. and Dedhar, S. (2007). Integrin-linked kinase at the heart of cardiac contractility, repair, and disease. Circ. Res. 100, 1408-1414.
42. Huang, J., Mahavadi, S., Sriwai W., Hu, W. and Murthy, K. S. (2006). Gi-coupled receptors mediate phosphorylation of CPI17 and MLC20 via preferential activation of the PI3K/ILK pathway. Biochem. J 396, 193-200.
43. Huang, Y., Li, J., Zhang, Y. and Wu, C. (2000). The roles of integrin-linked kinase in the regulation of myogenic differentiation. J. Cell Biol. 150, 861-872.
44. Imanishi, Y., Hu, B., Jarzynka, M. J., Goo, P., Elishaev, E., Bar-Joseph, I. and Cheng, S. Y. (2007). Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway. Cancer Res. 67, 4254-4263.
45. Jin, L., Tabe, Y., Konoplev, S., Xu, Y., Leysath, C. E., Lu, H., Kimura, S., Ohsaka, A., Rios, M. B., Calvert, L. et al. (2008). CXCR4 up-regulation by imatimb induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells. Mol. Cancer Ther. 7, 48-58.
46. Joshi, M. B., lvanov, D., Philippova, M., Erne, P. and Resink, T. J. (2007). Integrin-linked kinase is an essential mediator for T-cadberin-dependent signaling via Akt and GSK3 {beta} in endothelial cells. FASEB J 21, 3083-3095.
47. Kanasaki, K., Kanda, Y., Palmsten, K., Tanjore, H., Lee, S. B., Lebleu, V. S., Gattone, V. H., Jr and Kalluri, R. (2008). Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus. Dev. Biol. 313, 584-593.
48. Kim, Y. B., Choi, S., Choi, M. C., Oh, M. A., Lee, S. A., Cho, M., Mizouno, K., Kim, S. H. and Lee, J. W. (2008). Cell adhesion dependent cofilin serine-3 phosphorylation by integrin-linked kinase-c-Src complex. J. Biol. Chem. 283, 10089-10096.
49. Knoll, R., Postel, R., Wang, J., Kratzner, R., Hennecke, G., Vacurn, A. M., Vakeel, P., Schubert, C., Murthy, K., Rana, B. K. et al. (2007). Laminin-alpha4 and integrin-linked kinase mutations cause human cardiornyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation 116, 515-525.
50. Koul, D., Shen, R., Bergh, S., Lu, Y., de Groot, J. F., Liu, T. J., Mills, G. B. and Yung, W. K. (2005). Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma. Mol. Cancer Ther. 4, 1681-1688.
51. Kumar, A. S., Naruszewicz, I., Wang, P., Leung-Hagesteijn, C. and Hannigan, G. E. (2004). ILKAP regulates ILK signaling and inhibits anchorage-independent growth. Oncogene 23, 3454-3461.
52. Lee, S. P., Youn, S. W., Cho, H. J., Li, L., Kim, T. Y., Yook, H. S., Chung, J. W., Hur, J., Yoon, C. H., Park, K. W. et al. (2006). Integrin-linked kinase, a hypoxia-responsive molecule, controls postnatal vasculogenesis by recruitment of endothelial progenitor cells to ischemic tissue. Circulation 114, 150-159.
53. Legate, K. R., Montanez, E., Kudlacek, O. and Fussier, R. (2006). ILK, PINCH and parvin: the tIPP of integrin signalling. Nat. Rev. Mol. Cell. Biol. 7, 20-31.
54. Leung-Hagesteijn, C., Mahendra, A., Naruszewicz, I. and Hannigan, G. E. (2001). Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1. EMBO J. 20, 2160-2170.
55. Li, Y., Yang, J., Dai, C., Wu, C. and Liu, Y. (2003). Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J. Clin. Invest. 112, 503-516.
56. Lin, S. W., Ke, F. C., Hsiao, P. W., Lee, P. P., Lee, M. T. and Hwang, J. J. (2007). Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system. Exp. Cell Res. 313, 602-613.
57. Liu, E., Sinha, S., Williams, C., Cyrille, M., Heller, E., Snapper, S. B., Georgopoulos, K., St-Arnaud, R., Force, T., Dedhar, S. et al. (2005). Targeted deletion of integrin-linked kinase reveals arole in T-cell chemotaxis and survival. Mol. Cell. Biol. 25, 11145-11155.
58. Liu, J., Costello, P. C., Pham, N. A., Pintillie, M., Jabali, M., Sanghera, J., Tsao, M. S. and Johnston, M. R. (2006). Integrin-linked kinase inhibitor KP-392 demonstrates clinical benefits in an orthotopic human non-small cell lung cancer model. J. Thorac. Oncol. 1, 771-779.
59. Lorenz, K., Grashoff, C., Torka, R., Sakai, T., Langbein, L., Bloch, W., Aumailley, M. and Fassler, R. (2007). Integrin-linked kinase is required for epidermal and hair follicle morphogenesis. J. Cell Biol. 177, 501-513.
60. Mackinnon, A. C., Qadota, H., Norman, K. R., Moerman, D. G. and Williams, B. D. (2002). C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr. Biol. 12, 787-797.
61. McDonald, P. C., Oloumi, A., Mills, J., Dobreva, L, Maidan, M., Gray, V., Wederell, E. D., Bally, M. B., Foster, L. J. and Dedhar, S. (2008). Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res. 68, 1618-1624.
62. Miller, M. G., Naruszewicz, I., Kumar, A. S., Ramlal, T. and Hannigan, G. E. (2003). Integrin-linked kinase is a positive mediator of L6 myoblast differentiation. Biochem. Biophys. Res. Commun. 310, 796-803.
63. Mills, J., Digicaylioglu, M., Legg, A. T., Young, C. E., Young, S. S., Barr, A. M., Fletcher, L., O'Connor, T. P. and Dedhar, S. (2003). Role of integrin-linked kinase in nerve growth factor-stimulated neurite outgrowth. J. Neurosci. 23, 1638-1648.
64. Mills, J., Niewmierzycka, A., Oloumi, A., Rico, B., St-Arnaud, R., Mackenzie, I. R., Mawji, N. M., Wilson, J., Reichardt, L. F. and Dedhar, S. (2006). Critical role of integrin-linked kinase in granule cell precursor proliferation and cerebellar development. J. Neurosci. 26, 830-840.
65. Monferran, S., Skuli, N., Delmas, C., Favre, G., Bonnet, J., Cohen-Jonathan-Moyal, E. and Toulas, C. (2008). alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB. Int. J. Cancer 123, 357-364.
66. Muranyi, A., MacDonald, J. A., Deng, J. T., Wilson, D. P., Haystead, T. A., Walsh, M. P., Erdodi, F., Kiss, E., Wu, Y. and Hartshorne, D. J. (2002). Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase. Biochem. J. 366, 211-216.
67. Nakrieko, K. A., Welch, I., Dupuis, H., Bryce, D., Pajak, A., Arnaud, R. S., Dedhar, S., D'Souza, S. J. and Dagnino, L. (2008). Impaired hair follicle morphogenesis and polarized keratinocyte movement upon conditional inactivation of integrin-linked kinase in the epidermis. Mol. Biol. Cell 19, 1462-1473.
68. Naska, S., Park, K. J., Hannigan, G. E., Dedhar, S., Miller, F. D. and Kaplan, D. R. (2006). An essential role for the integrin-linked kinase-glycogen synthase kinase-3 beta pathway during dendrite initiation and growth. J. Neurosci. 26, 13344-13356.
69. Niewmierzycka, A., Mills, J., St-Arnaud, R., Dedhar, S. and Reichardt, L. F. (2005). Integrin-linked kinase deletion from mouse cortex results in cortical lamination defects resembling cobblestone lissencephaly. J. Neurosci. 25, 7022-7031.
70. Nikolopoulos, S. N. and Turner, C. E. (2001). Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions. J. Biol. Chem. 276, 23499-23505.
71. Nikolopoulos, S. N. and Turner, C. E. (2002). Molecular dissection of actopaxin-integrin-linked kinase-Paxillin interactions and their role in subcellular localization. J. Biol. Chem. 277, 1568-1575.
72. Oinuma, I., Katob, H. and Negishii, M. (2007). R-Ras controls axon specification upstream of glycogen synthase kinase-3beta through integrin-linked kinase. J. Biol. Chem. 282, 303-318.
73. Okumura, M., Yamaji, S., Nagashima, Y., Nishikawa, M., Yoshimoto, N., Kido, Y., Iemoto, Y., Aoki, I. and Ishigatsubo, Y. (2007). Prognostic value of integrin beta1-ILK-pAkt signaling pathway in non-small cell lung cancer. Hum. Pathol. 38, 1081-1091.
74. Oloumi, A., Syam, S. and Dedhar, S. (2006). Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells. Oncogene 25, 7747-7757.
75. Pasquali, C., Bertschy-Meier, D., Chabert, C., Curchod, M. L., Arod, C., Booth, R., Mechtler, K., Vilbois, F., Xenarios, L., Ferguson, C. G. et al. (2007). A chemical protcomics approach to phosphatidylinositol 3-kinase signaling in macrophages. Mol. Cell Proteomics 6, 1829-1841.
76. Peng, X., Kraus, M. S., Wei, H., Shen, T. L., Pariaut, R., Alcaraz, A., Ji, G., Cheng, L., Yang, Q., Kotlikoff, M. I. et al. (2006). Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice. J. Clin. Invest. 116, 217-227.
77. Persad, S., Attwell, S., Gray, V., Delcommenne, M., Troussard, A., Sanghera, J. and Dedhar, S. (2000). Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc. Natl. Acad Sci. USA 97, 3207-3212.
78. Persad, S., Troussard, A. A., McPhee, T. R., Mulholland, D. J. and Dedhar, S. (2001). Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J. Cell Biol. 153, 1161-1174.
79. Postel, R., Vakeel, P., Topczewski, J., Knoll, R. and Bakkers, J. (2008). Zebrafish integrin-linked kinase is required in skeletal muscles for strengthening the integrin-ECM adhesion complex. Dev. Biol. 318, 92-101.
80. Quelo, I., Gauthier, C., Hannigan, G. E., Dedhar, S. and St-Arnaud, R. (2004). Integrin-linked Kinase Regulates the Nuclear Entry of the c-Jun Coactivator {alpha}-NAC and Its Coactivation Potency. J. Biol. Chem. 279, 43893-43899.
81. Reverte, C. G., Benware, A., Jones, C. W. and LaFlamme, S. E. (2006). Perturbing integrin function inhibits microtubule growth from centrosomes, spindle assembly, and cytokinesis. J. Cell Biol. 174, 491-497.
82. Rosano, L., Spinella, F., Di Castro, V., Nicotra, M. R., Dedhar, S., de Herreros, A. G., Natall, P. G. and Bagnato, A. (2005). Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Cancer Res. 65, 11649-11657.
83. Rosano, L., Spinella, F., Di Castro, V., Dedhar, S., Nicotra, M. R., Natali, P. G. and Bagnato, A. (2006). Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma. Mol. Cancer Ther. 5, 833-842.
84. Sakai, T., Li, S., Docheva, D., Grashoff, C., Sakai, K., Kostka, G., Braun, A., Pfeifer, A., Yurchenco, P. D. and Fassler, R. (2003). Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev. 17, 926-940.
85. Sarbassov, D. D., Ali, S. M., Kim, D. H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P. and Sabatini, D. M. (2004). Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296-1302.
86. Sarbassov, D. D., Guertin, D. A., Ali, S. M. and Sabatini, D. M. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101.
87. Shai, S. Y., Harpf, A. E., Babbitt, C. J., Jordan, M. C., Fishbein, M. C., Chen, J., Omura, M., Leil, T. A., Becker, K. D., Jiang, M. et al. (2002). Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure. Circ. Res. 90, 458-464.
88. Shi, Q., Bao, S., Song, L., Wu, Q., Bigner, D. D., Hjelmeland, A. B. and Rich, J. N. (2007). Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases. Oncogene 26, 4084-4094.
89. Takanami, I. (2005). Increased expression of integrin-linked kinase is associated with shorter survival in non-small cell lung cancer. BMC Cancer 5, 1.
90. Tan, C., Mui, A. and Dedhar, S. (2002). Integrin-linked kinase regulates inducible nitric oxide synthase and cyclooxygenase-2 expression in an NF-kappa B-dependent manner. J. Biol. Chem. 277, 3109-3116.
91. Tan, C., Cruet-Hennequart, S., Troussard, A., Fazli L., Costello, P., Sutton, K., Wheeler, J., Gleave, M., Sanghera, J. and Dedhar, S. (2004). Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell 5, 79-90.
92. Terpstra, L., Prud'homme, J., Arabian, A., Takeda, S., Karsenty, G., Dedhar, S. and St-Arnaud, R. (2003). Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes. J. Cell Biol. 162, 139-148.
93. Troussard, A. A., Costello, P., Yoganathan, T. N., Kumagal, S., Roskelley, C. D. and Dedhar, S. (2000). The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene 19, 5444-5452.
94. Trousard, A. A., Mawji, N. M., Ong, C., Mui, A., St-Arnaud, R. and Dedhar, S. (2003). conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol. Chem. 278, 22374-22378.
95. Troussard, A. A., McDonald, P. C., Wederell, E. D., Mawji, N. M., Filipenko, N. R., Gelmon, K. A., Kucab, J. E., Dunn, S. E., Emerman, J. T., Bally, M. B. et al. (2006). Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival. Cancer Res. 66, 393-403.
96. Vouret-Craviari, V., Boulter, E., Grall, D., Matthews, C. and Van Obberghen-Schilling, E. (2004). ILK is required for the assembly of matrix-forming adhesions and capillary morphogenesis in endothelial cells. J Cell Sci. 117, 4559-4569.
97. Wang, H. V., Chang, L. W., Brixius, K., Wickstrom, S. A., Montanez, E., Thievessen, I., Schwander, M., Muller, U., Bloch, W., Mayer, U. et al. (2008). Integrin-linked kinase stabilizes myotendinous junctions and protects muscle from stress-induced damage. J. Cell Biol. 180, 1037-1049.
98. White, D. E., Coutu, P., Shi, Y. F., Tardif, J. C., Nattel, S., St Arnaud, R., Dedhar, S. and Muller, W. J. (2006). Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. Genes Dev. 20, 2355-2360.
99. Wong, R. P., Ng, P., Dedhar, S. and Li, G. (2007). The role of integrin-linked kinase in melanoma cell migration, invasion, and tumor growth. Mol. Cancer Ther. 6, 1692-1700.
100. Xie, D., Yin, D., Tong, X., O'Kelly, J., Mori, A., Miller, C., Black, K., Gui, D., Said, J. W. and Koeffler, H. P. (2004). Cyr6l is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res. 64, 1987-1996.
101. Yasunaga, T., Kusakabe, M., Yamanaka, H., Hanafasa, H., Masuyama, N. and Nishida, E. (2005). Xenopus ILK (integrin-linked kinase) is required for morphogenetic movements during gastrulation. Genes Cells 10, 369-379.
102. Yau, C. Y., Wheeler, J. J., Sutton, K. L. and Hedley, D. W. (2005). Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the P13K/PKI3/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts. Cancer Res. 65 1497-1504.
103. Yushimi, R., Yamaji S., Suzuki, A., Mishima, W., Okamura, M., Obana, T., Matsuda, C., Miwa, Y., Ohno, S. and Ishigatsubo, Y. (2006). ne gamma-parvin-integrin-linked kinase complex is critically involved in leukocyte-substrate interaction. J Immunol. 176, 3611-3624.
104. Younes, M. N., Kim, S., Yigitbasi, O. G., Mandal, M., Jasser, S. A., Dakak Yazici, Y., Schiff, B. A., El-Naggar, A., Bekele, B. N., Mills, G. B. et al. (2005). Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer. Mol. Cancer Ther. 4, 1146-1156.
105. Younes, M. N., Yigitbasi, O. G., Yazich Y. D., Jasser, S. A., Bucana, C. D., El-Naggar, A. K., Mills, G. B. and Myers, J. N. (2007). Effects ofthe integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg. 133, 15-23.
106. Zervas, C. G., Gregory, S. L. and Brown, N. H. (2001). Drosophila integrin-linked kinase is required at sites of integrin adhesion to link the cytoskeleton to the plasma membrane. J Cell Biol. 152, 1007-1018.
107. Zhang, W., Wu, Y., Wu, C. and Gunst, S. J. (2007). Integrin-linked kinase regulates N-WASp-mediated actin polymerization and tension development in tracheal smooth muscle. J. Biol. Chem. 282, 34568-34580.
108. Zhang, Y., Guo, L., Chen, K. and Wu, C. (2002). A critical role of the PINCH-integrin-linked kinase interaction in the regulation of cell shape change and migration. J. Biol. Chem. 277, 318-326.
109. Zhou, F. Q., Zhou, J., Dedhar, S., Wu, Y. H. and Snider, W. D. (2004). NGF-induced axon growth is mediated by localized inactivation of GSK-3beta and functions of the microtubule plus end binding protein APC. Neuron 42, 897-912.